Global Nervous System Chemicals Supply, Demand and Key Producers, 2023-2029
The global Nervous System Chemicals market size is expected to reach $ 114210 million by 2029, rising at a market growth of 4.8% CAGR during the forecast period (2023-2029).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Neurologic medications are medications used to treat various neurological disorders and disease symptoms.
This report studies the global Nervous System Chemicals production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nervous System Chemicals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nervous System Chemicals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nervous System Chemicals total production and demand, 2018-2029, (K Units)
Global Nervous System Chemicals total production value, 2018-2029, (USD Million)
Global Nervous System Chemicals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nervous System Chemicals consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nervous System Chemicals domestic production, consumption, key domestic manufacturers and share
Global Nervous System Chemicals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nervous System Chemicals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nervous System Chemicals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Nervous System Chemicals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Ely Lilly, Actavis(Teva Pharmaceuticals), Mylan(Viatris), UCB, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan(AbbVie), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nervous System Chemicals market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nervous System Chemicals Market, By Region:
1. How big is the global Nervous System Chemicals market?
2. What is the demand of the global Nervous System Chemicals market?
3. What is the year over year growth of the global Nervous System Chemicals market?
4. What is the production and production value of the global Nervous System Chemicals market?
5. Who are the key producers in the global Nervous System Chemicals market?
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Neurologic medications are medications used to treat various neurological disorders and disease symptoms.
This report studies the global Nervous System Chemicals production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nervous System Chemicals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nervous System Chemicals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nervous System Chemicals total production and demand, 2018-2029, (K Units)
Global Nervous System Chemicals total production value, 2018-2029, (USD Million)
Global Nervous System Chemicals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nervous System Chemicals consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Nervous System Chemicals domestic production, consumption, key domestic manufacturers and share
Global Nervous System Chemicals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Nervous System Chemicals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Nervous System Chemicals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Nervous System Chemicals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Ely Lilly, Actavis(Teva Pharmaceuticals), Mylan(Viatris), UCB, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan(AbbVie), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nervous System Chemicals market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Nervous System Chemicals Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Non-prescription Drugs
- Prescription
- Hospital
- Clinic
- Other
- Pfizer
- Ely Lilly
- Actavis(Teva Pharmaceuticals)
- Mylan(Viatris)
- UCB
- Intellipharmaceutics
- Astrazeneca
- Lundbeck
- Allergan(AbbVie)
- GSK
- Otsuka Pharmaceutical
- Takeda
- Novartis
- Johnson & Johnson
- Eisai
- Kelun Pharmaceutical
- Humanwell Pharmaceutical
- Enhua Pharmaceutical
- Yangzijiang Pharmaceutical
1. How big is the global Nervous System Chemicals market?
2. What is the demand of the global Nervous System Chemicals market?
3. What is the year over year growth of the global Nervous System Chemicals market?
4. What is the production and production value of the global Nervous System Chemicals market?
5. Who are the key producers in the global Nervous System Chemicals market?
1 SUPPLY SUMMARY
1.1 Nervous System Chemicals Introduction
1.2 World Nervous System Chemicals Supply & Forecast
1.2.1 World Nervous System Chemicals Production Value (2018 & 2022 & 2029)
1.2.2 World Nervous System Chemicals Production (2018-2029)
1.2.3 World Nervous System Chemicals Pricing Trends (2018-2029)
1.3 World Nervous System Chemicals Production by Region (Based on Production Site)
1.3.1 World Nervous System Chemicals Production Value by Region (2018-2029)
1.3.2 World Nervous System Chemicals Production by Region (2018-2029)
1.3.3 World Nervous System Chemicals Average Price by Region (2018-2029)
1.3.4 North America Nervous System Chemicals Production (2018-2029)
1.3.5 Europe Nervous System Chemicals Production (2018-2029)
1.3.6 China Nervous System Chemicals Production (2018-2029)
1.3.7 Japan Nervous System Chemicals Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nervous System Chemicals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nervous System Chemicals Major Market Trends
2 DEMAND SUMMARY
2.1 World Nervous System Chemicals Demand (2018-2029)
2.2 World Nervous System Chemicals Consumption by Region
2.2.1 World Nervous System Chemicals Consumption by Region (2018-2023)
2.2.2 World Nervous System Chemicals Consumption Forecast by Region (2024-2029)
2.3 United States Nervous System Chemicals Consumption (2018-2029)
2.4 China Nervous System Chemicals Consumption (2018-2029)
2.5 Europe Nervous System Chemicals Consumption (2018-2029)
2.6 Japan Nervous System Chemicals Consumption (2018-2029)
2.7 South Korea Nervous System Chemicals Consumption (2018-2029)
2.8 ASEAN Nervous System Chemicals Consumption (2018-2029)
2.9 India Nervous System Chemicals Consumption (2018-2029)
3 WORLD NERVOUS SYSTEM CHEMICALS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nervous System Chemicals Production Value by Manufacturer (2018-2023)
3.2 World Nervous System Chemicals Production by Manufacturer (2018-2023)
3.3 World Nervous System Chemicals Average Price by Manufacturer (2018-2023)
3.4 Nervous System Chemicals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nervous System Chemicals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nervous System Chemicals in 2022
3.5.3 Global Concentration Ratios (CR8) for Nervous System Chemicals in 2022
3.6 Nervous System Chemicals Market: Overall Company Footprint Analysis
3.6.1 Nervous System Chemicals Market: Region Footprint
3.6.2 Nervous System Chemicals Market: Company Product Type Footprint
3.6.3 Nervous System Chemicals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nervous System Chemicals Production Value Comparison
4.1.1 United States VS China: Nervous System Chemicals Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nervous System Chemicals Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nervous System Chemicals Production Comparison
4.2.1 United States VS China: Nervous System Chemicals Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nervous System Chemicals Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nervous System Chemicals Consumption Comparison
4.3.1 United States VS China: Nervous System Chemicals Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nervous System Chemicals Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nervous System Chemicals Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nervous System Chemicals Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nervous System Chemicals Production (2018-2023)
4.5 China Based Nervous System Chemicals Manufacturers and Market Share
4.5.1 China Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nervous System Chemicals Production Value (2018-2023)
4.5.3 China Based Manufacturers Nervous System Chemicals Production (2018-2023)
4.6 Rest of World Based Nervous System Chemicals Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nervous System Chemicals Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nervous System Chemicals Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nervous System Chemicals Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-prescription Drugs
5.2.2 Prescription
5.3 Market Segment by Type
5.3.1 World Nervous System Chemicals Production by Type (2018-2029)
5.3.2 World Nervous System Chemicals Production Value by Type (2018-2029)
5.3.3 World Nervous System Chemicals Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nervous System Chemicals Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Nervous System Chemicals Production by Application (2018-2029)
6.3.2 World Nervous System Chemicals Production Value by Application (2018-2029)
6.3.3 World Nervous System Chemicals Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Nervous System Chemicals Product and Services
7.1.4 Pfizer Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Ely Lilly
7.2.1 Ely Lilly Details
7.2.2 Ely Lilly Major Business
7.2.3 Ely Lilly Nervous System Chemicals Product and Services
7.2.4 Ely Lilly Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ely Lilly Recent Developments/Updates
7.2.6 Ely Lilly Competitive Strengths & Weaknesses
7.3 Actavis(Teva Pharmaceuticals)
7.3.1 Actavis(Teva Pharmaceuticals) Details
7.3.2 Actavis(Teva Pharmaceuticals) Major Business
7.3.3 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product and Services
7.3.4 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Actavis(Teva Pharmaceuticals) Recent Developments/Updates
7.3.6 Actavis(Teva Pharmaceuticals) Competitive Strengths & Weaknesses
7.4 Mylan(Viatris)
7.4.1 Mylan(Viatris) Details
7.4.2 Mylan(Viatris) Major Business
7.4.3 Mylan(Viatris) Nervous System Chemicals Product and Services
7.4.4 Mylan(Viatris) Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Mylan(Viatris) Recent Developments/Updates
7.4.6 Mylan(Viatris) Competitive Strengths & Weaknesses
7.5 UCB
7.5.1 UCB Details
7.5.2 UCB Major Business
7.5.3 UCB Nervous System Chemicals Product and Services
7.5.4 UCB Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 UCB Recent Developments/Updates
7.5.6 UCB Competitive Strengths & Weaknesses
7.6 Intellipharmaceutics
7.6.1 Intellipharmaceutics Details
7.6.2 Intellipharmaceutics Major Business
7.6.3 Intellipharmaceutics Nervous System Chemicals Product and Services
7.6.4 Intellipharmaceutics Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Intellipharmaceutics Recent Developments/Updates
7.6.6 Intellipharmaceutics Competitive Strengths & Weaknesses
7.7 Astrazeneca
7.7.1 Astrazeneca Details
7.7.2 Astrazeneca Major Business
7.7.3 Astrazeneca Nervous System Chemicals Product and Services
7.7.4 Astrazeneca Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Astrazeneca Recent Developments/Updates
7.7.6 Astrazeneca Competitive Strengths & Weaknesses
7.8 Lundbeck
7.8.1 Lundbeck Details
7.8.2 Lundbeck Major Business
7.8.3 Lundbeck Nervous System Chemicals Product and Services
7.8.4 Lundbeck Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Lundbeck Recent Developments/Updates
7.8.6 Lundbeck Competitive Strengths & Weaknesses
7.9 Allergan(AbbVie)
7.9.1 Allergan(AbbVie) Details
7.9.2 Allergan(AbbVie) Major Business
7.9.3 Allergan(AbbVie) Nervous System Chemicals Product and Services
7.9.4 Allergan(AbbVie) Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Allergan(AbbVie) Recent Developments/Updates
7.9.6 Allergan(AbbVie) Competitive Strengths & Weaknesses
7.10 GSK
7.10.1 GSK Details
7.10.2 GSK Major Business
7.10.3 GSK Nervous System Chemicals Product and Services
7.10.4 GSK Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GSK Recent Developments/Updates
7.10.6 GSK Competitive Strengths & Weaknesses
7.11 Otsuka Pharmaceutical
7.11.1 Otsuka Pharmaceutical Details
7.11.2 Otsuka Pharmaceutical Major Business
7.11.3 Otsuka Pharmaceutical Nervous System Chemicals Product and Services
7.11.4 Otsuka Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Otsuka Pharmaceutical Recent Developments/Updates
7.11.6 Otsuka Pharmaceutical Competitive Strengths & Weaknesses
7.12 Takeda
7.12.1 Takeda Details
7.12.2 Takeda Major Business
7.12.3 Takeda Nervous System Chemicals Product and Services
7.12.4 Takeda Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Takeda Recent Developments/Updates
7.12.6 Takeda Competitive Strengths & Weaknesses
7.13 Novartis
7.13.1 Novartis Details
7.13.2 Novartis Major Business
7.13.3 Novartis Nervous System Chemicals Product and Services
7.13.4 Novartis Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Novartis Recent Developments/Updates
7.13.6 Novartis Competitive Strengths & Weaknesses
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Details
7.14.2 Johnson & Johnson Major Business
7.14.3 Johnson & Johnson Nervous System Chemicals Product and Services
7.14.4 Johnson & Johnson Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Johnson & Johnson Recent Developments/Updates
7.14.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.15 Eisai
7.15.1 Eisai Details
7.15.2 Eisai Major Business
7.15.3 Eisai Nervous System Chemicals Product and Services
7.15.4 Eisai Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Eisai Recent Developments/Updates
7.15.6 Eisai Competitive Strengths & Weaknesses
7.16 Kelun Pharmaceutical
7.16.1 Kelun Pharmaceutical Details
7.16.2 Kelun Pharmaceutical Major Business
7.16.3 Kelun Pharmaceutical Nervous System Chemicals Product and Services
7.16.4 Kelun Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Kelun Pharmaceutical Recent Developments/Updates
7.16.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
7.17 Humanwell Pharmaceutical
7.17.1 Humanwell Pharmaceutical Details
7.17.2 Humanwell Pharmaceutical Major Business
7.17.3 Humanwell Pharmaceutical Nervous System Chemicals Product and Services
7.17.4 Humanwell Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Humanwell Pharmaceutical Recent Developments/Updates
7.17.6 Humanwell Pharmaceutical Competitive Strengths & Weaknesses
7.18 Enhua Pharmaceutical
7.18.1 Enhua Pharmaceutical Details
7.18.2 Enhua Pharmaceutical Major Business
7.18.3 Enhua Pharmaceutical Nervous System Chemicals Product and Services
7.18.4 Enhua Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Enhua Pharmaceutical Recent Developments/Updates
7.18.6 Enhua Pharmaceutical Competitive Strengths & Weaknesses
7.19 Yangzijiang Pharmaceutical
7.19.1 Yangzijiang Pharmaceutical Details
7.19.2 Yangzijiang Pharmaceutical Major Business
7.19.3 Yangzijiang Pharmaceutical Nervous System Chemicals Product and Services
7.19.4 Yangzijiang Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Yangzijiang Pharmaceutical Recent Developments/Updates
7.19.6 Yangzijiang Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nervous System Chemicals Industry Chain
8.2 Nervous System Chemicals Upstream Analysis
8.2.1 Nervous System Chemicals Core Raw Materials
8.2.2 Main Manufacturers of Nervous System Chemicals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nervous System Chemicals Production Mode
8.6 Nervous System Chemicals Procurement Model
8.7 Nervous System Chemicals Industry Sales Model and Sales Channels
8.7.1 Nervous System Chemicals Sales Model
8.7.2 Nervous System Chemicals Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Nervous System Chemicals Introduction
1.2 World Nervous System Chemicals Supply & Forecast
1.2.1 World Nervous System Chemicals Production Value (2018 & 2022 & 2029)
1.2.2 World Nervous System Chemicals Production (2018-2029)
1.2.3 World Nervous System Chemicals Pricing Trends (2018-2029)
1.3 World Nervous System Chemicals Production by Region (Based on Production Site)
1.3.1 World Nervous System Chemicals Production Value by Region (2018-2029)
1.3.2 World Nervous System Chemicals Production by Region (2018-2029)
1.3.3 World Nervous System Chemicals Average Price by Region (2018-2029)
1.3.4 North America Nervous System Chemicals Production (2018-2029)
1.3.5 Europe Nervous System Chemicals Production (2018-2029)
1.3.6 China Nervous System Chemicals Production (2018-2029)
1.3.7 Japan Nervous System Chemicals Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Nervous System Chemicals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Nervous System Chemicals Major Market Trends
2 DEMAND SUMMARY
2.1 World Nervous System Chemicals Demand (2018-2029)
2.2 World Nervous System Chemicals Consumption by Region
2.2.1 World Nervous System Chemicals Consumption by Region (2018-2023)
2.2.2 World Nervous System Chemicals Consumption Forecast by Region (2024-2029)
2.3 United States Nervous System Chemicals Consumption (2018-2029)
2.4 China Nervous System Chemicals Consumption (2018-2029)
2.5 Europe Nervous System Chemicals Consumption (2018-2029)
2.6 Japan Nervous System Chemicals Consumption (2018-2029)
2.7 South Korea Nervous System Chemicals Consumption (2018-2029)
2.8 ASEAN Nervous System Chemicals Consumption (2018-2029)
2.9 India Nervous System Chemicals Consumption (2018-2029)
3 WORLD NERVOUS SYSTEM CHEMICALS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Nervous System Chemicals Production Value by Manufacturer (2018-2023)
3.2 World Nervous System Chemicals Production by Manufacturer (2018-2023)
3.3 World Nervous System Chemicals Average Price by Manufacturer (2018-2023)
3.4 Nervous System Chemicals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Nervous System Chemicals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Nervous System Chemicals in 2022
3.5.3 Global Concentration Ratios (CR8) for Nervous System Chemicals in 2022
3.6 Nervous System Chemicals Market: Overall Company Footprint Analysis
3.6.1 Nervous System Chemicals Market: Region Footprint
3.6.2 Nervous System Chemicals Market: Company Product Type Footprint
3.6.3 Nervous System Chemicals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Nervous System Chemicals Production Value Comparison
4.1.1 United States VS China: Nervous System Chemicals Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Nervous System Chemicals Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Nervous System Chemicals Production Comparison
4.2.1 United States VS China: Nervous System Chemicals Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Nervous System Chemicals Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Nervous System Chemicals Consumption Comparison
4.3.1 United States VS China: Nervous System Chemicals Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Nervous System Chemicals Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Nervous System Chemicals Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Nervous System Chemicals Production Value (2018-2023)
4.4.3 United States Based Manufacturers Nervous System Chemicals Production (2018-2023)
4.5 China Based Nervous System Chemicals Manufacturers and Market Share
4.5.1 China Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Nervous System Chemicals Production Value (2018-2023)
4.5.3 China Based Manufacturers Nervous System Chemicals Production (2018-2023)
4.6 Rest of World Based Nervous System Chemicals Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Nervous System Chemicals Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Nervous System Chemicals Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Nervous System Chemicals Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Non-prescription Drugs
5.2.2 Prescription
5.3 Market Segment by Type
5.3.1 World Nervous System Chemicals Production by Type (2018-2029)
5.3.2 World Nervous System Chemicals Production Value by Type (2018-2029)
5.3.3 World Nervous System Chemicals Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Nervous System Chemicals Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Nervous System Chemicals Production by Application (2018-2029)
6.3.2 World Nervous System Chemicals Production Value by Application (2018-2029)
6.3.3 World Nervous System Chemicals Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Nervous System Chemicals Product and Services
7.1.4 Pfizer Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Ely Lilly
7.2.1 Ely Lilly Details
7.2.2 Ely Lilly Major Business
7.2.3 Ely Lilly Nervous System Chemicals Product and Services
7.2.4 Ely Lilly Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Ely Lilly Recent Developments/Updates
7.2.6 Ely Lilly Competitive Strengths & Weaknesses
7.3 Actavis(Teva Pharmaceuticals)
7.3.1 Actavis(Teva Pharmaceuticals) Details
7.3.2 Actavis(Teva Pharmaceuticals) Major Business
7.3.3 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product and Services
7.3.4 Actavis(Teva Pharmaceuticals) Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Actavis(Teva Pharmaceuticals) Recent Developments/Updates
7.3.6 Actavis(Teva Pharmaceuticals) Competitive Strengths & Weaknesses
7.4 Mylan(Viatris)
7.4.1 Mylan(Viatris) Details
7.4.2 Mylan(Viatris) Major Business
7.4.3 Mylan(Viatris) Nervous System Chemicals Product and Services
7.4.4 Mylan(Viatris) Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Mylan(Viatris) Recent Developments/Updates
7.4.6 Mylan(Viatris) Competitive Strengths & Weaknesses
7.5 UCB
7.5.1 UCB Details
7.5.2 UCB Major Business
7.5.3 UCB Nervous System Chemicals Product and Services
7.5.4 UCB Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 UCB Recent Developments/Updates
7.5.6 UCB Competitive Strengths & Weaknesses
7.6 Intellipharmaceutics
7.6.1 Intellipharmaceutics Details
7.6.2 Intellipharmaceutics Major Business
7.6.3 Intellipharmaceutics Nervous System Chemicals Product and Services
7.6.4 Intellipharmaceutics Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Intellipharmaceutics Recent Developments/Updates
7.6.6 Intellipharmaceutics Competitive Strengths & Weaknesses
7.7 Astrazeneca
7.7.1 Astrazeneca Details
7.7.2 Astrazeneca Major Business
7.7.3 Astrazeneca Nervous System Chemicals Product and Services
7.7.4 Astrazeneca Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Astrazeneca Recent Developments/Updates
7.7.6 Astrazeneca Competitive Strengths & Weaknesses
7.8 Lundbeck
7.8.1 Lundbeck Details
7.8.2 Lundbeck Major Business
7.8.3 Lundbeck Nervous System Chemicals Product and Services
7.8.4 Lundbeck Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Lundbeck Recent Developments/Updates
7.8.6 Lundbeck Competitive Strengths & Weaknesses
7.9 Allergan(AbbVie)
7.9.1 Allergan(AbbVie) Details
7.9.2 Allergan(AbbVie) Major Business
7.9.3 Allergan(AbbVie) Nervous System Chemicals Product and Services
7.9.4 Allergan(AbbVie) Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Allergan(AbbVie) Recent Developments/Updates
7.9.6 Allergan(AbbVie) Competitive Strengths & Weaknesses
7.10 GSK
7.10.1 GSK Details
7.10.2 GSK Major Business
7.10.3 GSK Nervous System Chemicals Product and Services
7.10.4 GSK Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GSK Recent Developments/Updates
7.10.6 GSK Competitive Strengths & Weaknesses
7.11 Otsuka Pharmaceutical
7.11.1 Otsuka Pharmaceutical Details
7.11.2 Otsuka Pharmaceutical Major Business
7.11.3 Otsuka Pharmaceutical Nervous System Chemicals Product and Services
7.11.4 Otsuka Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Otsuka Pharmaceutical Recent Developments/Updates
7.11.6 Otsuka Pharmaceutical Competitive Strengths & Weaknesses
7.12 Takeda
7.12.1 Takeda Details
7.12.2 Takeda Major Business
7.12.3 Takeda Nervous System Chemicals Product and Services
7.12.4 Takeda Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Takeda Recent Developments/Updates
7.12.6 Takeda Competitive Strengths & Weaknesses
7.13 Novartis
7.13.1 Novartis Details
7.13.2 Novartis Major Business
7.13.3 Novartis Nervous System Chemicals Product and Services
7.13.4 Novartis Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Novartis Recent Developments/Updates
7.13.6 Novartis Competitive Strengths & Weaknesses
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Details
7.14.2 Johnson & Johnson Major Business
7.14.3 Johnson & Johnson Nervous System Chemicals Product and Services
7.14.4 Johnson & Johnson Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Johnson & Johnson Recent Developments/Updates
7.14.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.15 Eisai
7.15.1 Eisai Details
7.15.2 Eisai Major Business
7.15.3 Eisai Nervous System Chemicals Product and Services
7.15.4 Eisai Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Eisai Recent Developments/Updates
7.15.6 Eisai Competitive Strengths & Weaknesses
7.16 Kelun Pharmaceutical
7.16.1 Kelun Pharmaceutical Details
7.16.2 Kelun Pharmaceutical Major Business
7.16.3 Kelun Pharmaceutical Nervous System Chemicals Product and Services
7.16.4 Kelun Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Kelun Pharmaceutical Recent Developments/Updates
7.16.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
7.17 Humanwell Pharmaceutical
7.17.1 Humanwell Pharmaceutical Details
7.17.2 Humanwell Pharmaceutical Major Business
7.17.3 Humanwell Pharmaceutical Nervous System Chemicals Product and Services
7.17.4 Humanwell Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Humanwell Pharmaceutical Recent Developments/Updates
7.17.6 Humanwell Pharmaceutical Competitive Strengths & Weaknesses
7.18 Enhua Pharmaceutical
7.18.1 Enhua Pharmaceutical Details
7.18.2 Enhua Pharmaceutical Major Business
7.18.3 Enhua Pharmaceutical Nervous System Chemicals Product and Services
7.18.4 Enhua Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Enhua Pharmaceutical Recent Developments/Updates
7.18.6 Enhua Pharmaceutical Competitive Strengths & Weaknesses
7.19 Yangzijiang Pharmaceutical
7.19.1 Yangzijiang Pharmaceutical Details
7.19.2 Yangzijiang Pharmaceutical Major Business
7.19.3 Yangzijiang Pharmaceutical Nervous System Chemicals Product and Services
7.19.4 Yangzijiang Pharmaceutical Nervous System Chemicals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Yangzijiang Pharmaceutical Recent Developments/Updates
7.19.6 Yangzijiang Pharmaceutical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Nervous System Chemicals Industry Chain
8.2 Nervous System Chemicals Upstream Analysis
8.2.1 Nervous System Chemicals Core Raw Materials
8.2.2 Main Manufacturers of Nervous System Chemicals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Nervous System Chemicals Production Mode
8.6 Nervous System Chemicals Procurement Model
8.7 Nervous System Chemicals Industry Sales Model and Sales Channels
8.7.1 Nervous System Chemicals Sales Model
8.7.2 Nervous System Chemicals Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Nervous System Chemicals Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nervous System Chemicals Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nervous System Chemicals Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nervous System Chemicals Production Value Market Share by Region (2018-2023)
Table 5. World Nervous System Chemicals Production Value Market Share by Region (2024-2029)
Table 6. World Nervous System Chemicals Production by Region (2018-2023) & (K Units)
Table 7. World Nervous System Chemicals Production by Region (2024-2029) & (K Units)
Table 8. World Nervous System Chemicals Production Market Share by Region (2018-2023)
Table 9. World Nervous System Chemicals Production Market Share by Region (2024-2029)
Table 10. World Nervous System Chemicals Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nervous System Chemicals Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nervous System Chemicals Major Market Trends
Table 13. World Nervous System Chemicals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nervous System Chemicals Consumption by Region (2018-2023) & (K Units)
Table 15. World Nervous System Chemicals Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nervous System Chemicals Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nervous System Chemicals Producers in 2022
Table 18. World Nervous System Chemicals Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nervous System Chemicals Producers in 2022
Table 20. World Nervous System Chemicals Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nervous System Chemicals Company Evaluation Quadrant
Table 22. World Nervous System Chemicals Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nervous System Chemicals Production Site of Key Manufacturer
Table 24. Nervous System Chemicals Market: Company Product Type Footprint
Table 25. Nervous System Chemicals Market: Company Product Application Footprint
Table 26. Nervous System Chemicals Competitive Factors
Table 27. Nervous System Chemicals New Entrant and Capacity Expansion Plans
Table 28. Nervous System Chemicals Mergers & Acquisitions Activity
Table 29. United States VS China Nervous System Chemicals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nervous System Chemicals Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nervous System Chemicals Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nervous System Chemicals Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nervous System Chemicals Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nervous System Chemicals Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nervous System Chemicals Production Market Share (2018-2023)
Table 37. China Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nervous System Chemicals Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nervous System Chemicals Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nervous System Chemicals Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nervous System Chemicals Production Market Share (2018-2023)
Table 42. Rest of World Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nervous System Chemicals Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nervous System Chemicals Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nervous System Chemicals Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nervous System Chemicals Production Market Share (2018-2023)
Table 47. World Nervous System Chemicals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nervous System Chemicals Production by Type (2018-2023) & (K Units)
Table 49. World Nervous System Chemicals Production by Type (2024-2029) & (K Units)
Table 50. World Nervous System Chemicals Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nervous System Chemicals Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nervous System Chemicals Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nervous System Chemicals Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nervous System Chemicals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nervous System Chemicals Production by Application (2018-2023) & (K Units)
Table 56. World Nervous System Chemicals Production by Application (2024-2029) & (K Units)
Table 57. World Nervous System Chemicals Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nervous System Chemicals Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nervous System Chemicals Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nervous System Chemicals Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Nervous System Chemicals Product and Services
Table 64. Pfizer Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Ely Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Ely Lilly Major Business
Table 69. Ely Lilly Nervous System Chemicals Product and Services
Table 70. Ely Lilly Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ely Lilly Recent Developments/Updates
Table 72. Ely Lilly Competitive Strengths & Weaknesses
Table 73. Actavis(Teva Pharmaceuticals) Basic Information, Manufacturing Base and Competitors
Table 74. Actavis(Teva Pharmaceuticals) Major Business
Table 75. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product and Services
Table 76. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Actavis(Teva Pharmaceuticals) Recent Developments/Updates
Table 78. Actavis(Teva Pharmaceuticals) Competitive Strengths & Weaknesses
Table 79. Mylan(Viatris) Basic Information, Manufacturing Base and Competitors
Table 80. Mylan(Viatris) Major Business
Table 81. Mylan(Viatris) Nervous System Chemicals Product and Services
Table 82. Mylan(Viatris) Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Mylan(Viatris) Recent Developments/Updates
Table 84. Mylan(Viatris) Competitive Strengths & Weaknesses
Table 85. UCB Basic Information, Manufacturing Base and Competitors
Table 86. UCB Major Business
Table 87. UCB Nervous System Chemicals Product and Services
Table 88. UCB Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. UCB Recent Developments/Updates
Table 90. UCB Competitive Strengths & Weaknesses
Table 91. Intellipharmaceutics Basic Information, Manufacturing Base and Competitors
Table 92. Intellipharmaceutics Major Business
Table 93. Intellipharmaceutics Nervous System Chemicals Product and Services
Table 94. Intellipharmaceutics Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Intellipharmaceutics Recent Developments/Updates
Table 96. Intellipharmaceutics Competitive Strengths & Weaknesses
Table 97. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 98. Astrazeneca Major Business
Table 99. Astrazeneca Nervous System Chemicals Product and Services
Table 100. Astrazeneca Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Astrazeneca Recent Developments/Updates
Table 102. Astrazeneca Competitive Strengths & Weaknesses
Table 103. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 104. Lundbeck Major Business
Table 105. Lundbeck Nervous System Chemicals Product and Services
Table 106. Lundbeck Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Lundbeck Recent Developments/Updates
Table 108. Lundbeck Competitive Strengths & Weaknesses
Table 109. Allergan(AbbVie) Basic Information, Manufacturing Base and Competitors
Table 110. Allergan(AbbVie) Major Business
Table 111. Allergan(AbbVie) Nervous System Chemicals Product and Services
Table 112. Allergan(AbbVie) Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Allergan(AbbVie) Recent Developments/Updates
Table 114. Allergan(AbbVie) Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK Nervous System Chemicals Product and Services
Table 118. GSK Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Otsuka Pharmaceutical Major Business
Table 123. Otsuka Pharmaceutical Nervous System Chemicals Product and Services
Table 124. Otsuka Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Otsuka Pharmaceutical Recent Developments/Updates
Table 126. Otsuka Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Takeda Basic Information, Manufacturing Base and Competitors
Table 128. Takeda Major Business
Table 129. Takeda Nervous System Chemicals Product and Services
Table 130. Takeda Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Takeda Recent Developments/Updates
Table 132. Takeda Competitive Strengths & Weaknesses
Table 133. Novartis Basic Information, Manufacturing Base and Competitors
Table 134. Novartis Major Business
Table 135. Novartis Nervous System Chemicals Product and Services
Table 136. Novartis Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Novartis Recent Developments/Updates
Table 138. Novartis Competitive Strengths & Weaknesses
Table 139. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 140. Johnson & Johnson Major Business
Table 141. Johnson & Johnson Nervous System Chemicals Product and Services
Table 142. Johnson & Johnson Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Johnson & Johnson Recent Developments/Updates
Table 144. Johnson & Johnson Competitive Strengths & Weaknesses
Table 145. Eisai Basic Information, Manufacturing Base and Competitors
Table 146. Eisai Major Business
Table 147. Eisai Nervous System Chemicals Product and Services
Table 148. Eisai Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Eisai Recent Developments/Updates
Table 150. Eisai Competitive Strengths & Weaknesses
Table 151. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Kelun Pharmaceutical Major Business
Table 153. Kelun Pharmaceutical Nervous System Chemicals Product and Services
Table 154. Kelun Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Kelun Pharmaceutical Recent Developments/Updates
Table 156. Kelun Pharmaceutical Competitive Strengths & Weaknesses
Table 157. Humanwell Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 158. Humanwell Pharmaceutical Major Business
Table 159. Humanwell Pharmaceutical Nervous System Chemicals Product and Services
Table 160. Humanwell Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Humanwell Pharmaceutical Recent Developments/Updates
Table 162. Humanwell Pharmaceutical Competitive Strengths & Weaknesses
Table 163. Enhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 164. Enhua Pharmaceutical Major Business
Table 165. Enhua Pharmaceutical Nervous System Chemicals Product and Services
Table 166. Enhua Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Enhua Pharmaceutical Recent Developments/Updates
Table 168. Yangzijiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 169. Yangzijiang Pharmaceutical Major Business
Table 170. Yangzijiang Pharmaceutical Nervous System Chemicals Product and Services
Table 171. Yangzijiang Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Nervous System Chemicals Upstream (Raw Materials)
Table 173. Nervous System Chemicals Typical Customers
Table 174. Nervous System Chemicals Typical Distributors
LIST OF FIGURE
Figure 1. Nervous System Chemicals Picture
Figure 2. World Nervous System Chemicals Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nervous System Chemicals Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 5. World Nervous System Chemicals Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nervous System Chemicals Production Value Market Share by Region (2018-2029)
Figure 7. World Nervous System Chemicals Production Market Share by Region (2018-2029)
Figure 8. North America Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 9. Europe Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 10. China Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 11. Japan Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 12. Nervous System Chemicals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 15. World Nervous System Chemicals Consumption Market Share by Region (2018-2029)
Figure 16. United States Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 17. China Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 18. Europe Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 19. Japan Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 22. India Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nervous System Chemicals by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nervous System Chemicals Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nervous System Chemicals Markets in 2022
Figure 26. United States VS China: Nervous System Chemicals Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nervous System Chemicals Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nervous System Chemicals Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nervous System Chemicals Production Market Share 2022
Figure 30. China Based Manufacturers Nervous System Chemicals Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nervous System Chemicals Production Market Share 2022
Figure 32. World Nervous System Chemicals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nervous System Chemicals Production Value Market Share by Type in 2022
Figure 34. Non-prescription Drugs
Figure 35. Prescription
Figure 36. World Nervous System Chemicals Production Market Share by Type (2018-2029)
Figure 37. World Nervous System Chemicals Production Value Market Share by Type (2018-2029)
Figure 38. World Nervous System Chemicals Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Nervous System Chemicals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Nervous System Chemicals Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Nervous System Chemicals Production Market Share by Application (2018-2029)
Figure 45. World Nervous System Chemicals Production Value Market Share by Application (2018-2029)
Figure 46. World Nervous System Chemicals Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Nervous System Chemicals Industry Chain
Figure 48. Nervous System Chemicals Procurement Model
Figure 49. Nervous System Chemicals Sales Model
Figure 50. Nervous System Chemicals Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Nervous System Chemicals Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Nervous System Chemicals Production Value by Region (2018-2023) & (USD Million)
Table 3. World Nervous System Chemicals Production Value by Region (2024-2029) & (USD Million)
Table 4. World Nervous System Chemicals Production Value Market Share by Region (2018-2023)
Table 5. World Nervous System Chemicals Production Value Market Share by Region (2024-2029)
Table 6. World Nervous System Chemicals Production by Region (2018-2023) & (K Units)
Table 7. World Nervous System Chemicals Production by Region (2024-2029) & (K Units)
Table 8. World Nervous System Chemicals Production Market Share by Region (2018-2023)
Table 9. World Nervous System Chemicals Production Market Share by Region (2024-2029)
Table 10. World Nervous System Chemicals Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Nervous System Chemicals Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Nervous System Chemicals Major Market Trends
Table 13. World Nervous System Chemicals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Nervous System Chemicals Consumption by Region (2018-2023) & (K Units)
Table 15. World Nervous System Chemicals Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Nervous System Chemicals Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Nervous System Chemicals Producers in 2022
Table 18. World Nervous System Chemicals Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Nervous System Chemicals Producers in 2022
Table 20. World Nervous System Chemicals Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Nervous System Chemicals Company Evaluation Quadrant
Table 22. World Nervous System Chemicals Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Nervous System Chemicals Production Site of Key Manufacturer
Table 24. Nervous System Chemicals Market: Company Product Type Footprint
Table 25. Nervous System Chemicals Market: Company Product Application Footprint
Table 26. Nervous System Chemicals Competitive Factors
Table 27. Nervous System Chemicals New Entrant and Capacity Expansion Plans
Table 28. Nervous System Chemicals Mergers & Acquisitions Activity
Table 29. United States VS China Nervous System Chemicals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Nervous System Chemicals Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Nervous System Chemicals Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Nervous System Chemicals Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Nervous System Chemicals Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Nervous System Chemicals Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Nervous System Chemicals Production Market Share (2018-2023)
Table 37. China Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Nervous System Chemicals Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Nervous System Chemicals Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Nervous System Chemicals Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Nervous System Chemicals Production Market Share (2018-2023)
Table 42. Rest of World Based Nervous System Chemicals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Nervous System Chemicals Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Nervous System Chemicals Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Nervous System Chemicals Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Nervous System Chemicals Production Market Share (2018-2023)
Table 47. World Nervous System Chemicals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Nervous System Chemicals Production by Type (2018-2023) & (K Units)
Table 49. World Nervous System Chemicals Production by Type (2024-2029) & (K Units)
Table 50. World Nervous System Chemicals Production Value by Type (2018-2023) & (USD Million)
Table 51. World Nervous System Chemicals Production Value by Type (2024-2029) & (USD Million)
Table 52. World Nervous System Chemicals Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Nervous System Chemicals Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Nervous System Chemicals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Nervous System Chemicals Production by Application (2018-2023) & (K Units)
Table 56. World Nervous System Chemicals Production by Application (2024-2029) & (K Units)
Table 57. World Nervous System Chemicals Production Value by Application (2018-2023) & (USD Million)
Table 58. World Nervous System Chemicals Production Value by Application (2024-2029) & (USD Million)
Table 59. World Nervous System Chemicals Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Nervous System Chemicals Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Nervous System Chemicals Product and Services
Table 64. Pfizer Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Ely Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Ely Lilly Major Business
Table 69. Ely Lilly Nervous System Chemicals Product and Services
Table 70. Ely Lilly Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Ely Lilly Recent Developments/Updates
Table 72. Ely Lilly Competitive Strengths & Weaknesses
Table 73. Actavis(Teva Pharmaceuticals) Basic Information, Manufacturing Base and Competitors
Table 74. Actavis(Teva Pharmaceuticals) Major Business
Table 75. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Product and Services
Table 76. Actavis(Teva Pharmaceuticals) Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Actavis(Teva Pharmaceuticals) Recent Developments/Updates
Table 78. Actavis(Teva Pharmaceuticals) Competitive Strengths & Weaknesses
Table 79. Mylan(Viatris) Basic Information, Manufacturing Base and Competitors
Table 80. Mylan(Viatris) Major Business
Table 81. Mylan(Viatris) Nervous System Chemicals Product and Services
Table 82. Mylan(Viatris) Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Mylan(Viatris) Recent Developments/Updates
Table 84. Mylan(Viatris) Competitive Strengths & Weaknesses
Table 85. UCB Basic Information, Manufacturing Base and Competitors
Table 86. UCB Major Business
Table 87. UCB Nervous System Chemicals Product and Services
Table 88. UCB Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. UCB Recent Developments/Updates
Table 90. UCB Competitive Strengths & Weaknesses
Table 91. Intellipharmaceutics Basic Information, Manufacturing Base and Competitors
Table 92. Intellipharmaceutics Major Business
Table 93. Intellipharmaceutics Nervous System Chemicals Product and Services
Table 94. Intellipharmaceutics Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Intellipharmaceutics Recent Developments/Updates
Table 96. Intellipharmaceutics Competitive Strengths & Weaknesses
Table 97. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 98. Astrazeneca Major Business
Table 99. Astrazeneca Nervous System Chemicals Product and Services
Table 100. Astrazeneca Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Astrazeneca Recent Developments/Updates
Table 102. Astrazeneca Competitive Strengths & Weaknesses
Table 103. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 104. Lundbeck Major Business
Table 105. Lundbeck Nervous System Chemicals Product and Services
Table 106. Lundbeck Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Lundbeck Recent Developments/Updates
Table 108. Lundbeck Competitive Strengths & Weaknesses
Table 109. Allergan(AbbVie) Basic Information, Manufacturing Base and Competitors
Table 110. Allergan(AbbVie) Major Business
Table 111. Allergan(AbbVie) Nervous System Chemicals Product and Services
Table 112. Allergan(AbbVie) Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Allergan(AbbVie) Recent Developments/Updates
Table 114. Allergan(AbbVie) Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK Nervous System Chemicals Product and Services
Table 118. GSK Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Otsuka Pharmaceutical Major Business
Table 123. Otsuka Pharmaceutical Nervous System Chemicals Product and Services
Table 124. Otsuka Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Otsuka Pharmaceutical Recent Developments/Updates
Table 126. Otsuka Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Takeda Basic Information, Manufacturing Base and Competitors
Table 128. Takeda Major Business
Table 129. Takeda Nervous System Chemicals Product and Services
Table 130. Takeda Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Takeda Recent Developments/Updates
Table 132. Takeda Competitive Strengths & Weaknesses
Table 133. Novartis Basic Information, Manufacturing Base and Competitors
Table 134. Novartis Major Business
Table 135. Novartis Nervous System Chemicals Product and Services
Table 136. Novartis Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Novartis Recent Developments/Updates
Table 138. Novartis Competitive Strengths & Weaknesses
Table 139. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 140. Johnson & Johnson Major Business
Table 141. Johnson & Johnson Nervous System Chemicals Product and Services
Table 142. Johnson & Johnson Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Johnson & Johnson Recent Developments/Updates
Table 144. Johnson & Johnson Competitive Strengths & Weaknesses
Table 145. Eisai Basic Information, Manufacturing Base and Competitors
Table 146. Eisai Major Business
Table 147. Eisai Nervous System Chemicals Product and Services
Table 148. Eisai Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Eisai Recent Developments/Updates
Table 150. Eisai Competitive Strengths & Weaknesses
Table 151. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 152. Kelun Pharmaceutical Major Business
Table 153. Kelun Pharmaceutical Nervous System Chemicals Product and Services
Table 154. Kelun Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Kelun Pharmaceutical Recent Developments/Updates
Table 156. Kelun Pharmaceutical Competitive Strengths & Weaknesses
Table 157. Humanwell Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 158. Humanwell Pharmaceutical Major Business
Table 159. Humanwell Pharmaceutical Nervous System Chemicals Product and Services
Table 160. Humanwell Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Humanwell Pharmaceutical Recent Developments/Updates
Table 162. Humanwell Pharmaceutical Competitive Strengths & Weaknesses
Table 163. Enhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 164. Enhua Pharmaceutical Major Business
Table 165. Enhua Pharmaceutical Nervous System Chemicals Product and Services
Table 166. Enhua Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Enhua Pharmaceutical Recent Developments/Updates
Table 168. Yangzijiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 169. Yangzijiang Pharmaceutical Major Business
Table 170. Yangzijiang Pharmaceutical Nervous System Chemicals Product and Services
Table 171. Yangzijiang Pharmaceutical Nervous System Chemicals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Nervous System Chemicals Upstream (Raw Materials)
Table 173. Nervous System Chemicals Typical Customers
Table 174. Nervous System Chemicals Typical Distributors
LIST OF FIGURE
Figure 1. Nervous System Chemicals Picture
Figure 2. World Nervous System Chemicals Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Nervous System Chemicals Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 5. World Nervous System Chemicals Average Price (2018-2029) & (US$/Unit)
Figure 6. World Nervous System Chemicals Production Value Market Share by Region (2018-2029)
Figure 7. World Nervous System Chemicals Production Market Share by Region (2018-2029)
Figure 8. North America Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 9. Europe Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 10. China Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 11. Japan Nervous System Chemicals Production (2018-2029) & (K Units)
Figure 12. Nervous System Chemicals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 15. World Nervous System Chemicals Consumption Market Share by Region (2018-2029)
Figure 16. United States Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 17. China Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 18. Europe Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 19. Japan Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 20. South Korea Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 22. India Nervous System Chemicals Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Nervous System Chemicals by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Nervous System Chemicals Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Nervous System Chemicals Markets in 2022
Figure 26. United States VS China: Nervous System Chemicals Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Nervous System Chemicals Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Nervous System Chemicals Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Nervous System Chemicals Production Market Share 2022
Figure 30. China Based Manufacturers Nervous System Chemicals Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Nervous System Chemicals Production Market Share 2022
Figure 32. World Nervous System Chemicals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Nervous System Chemicals Production Value Market Share by Type in 2022
Figure 34. Non-prescription Drugs
Figure 35. Prescription
Figure 36. World Nervous System Chemicals Production Market Share by Type (2018-2029)
Figure 37. World Nervous System Chemicals Production Value Market Share by Type (2018-2029)
Figure 38. World Nervous System Chemicals Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Nervous System Chemicals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Nervous System Chemicals Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. Other
Figure 44. World Nervous System Chemicals Production Market Share by Application (2018-2029)
Figure 45. World Nervous System Chemicals Production Value Market Share by Application (2018-2029)
Figure 46. World Nervous System Chemicals Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Nervous System Chemicals Industry Chain
Figure 48. Nervous System Chemicals Procurement Model
Figure 49. Nervous System Chemicals Sales Model
Figure 50. Nervous System Chemicals Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
